Company: MYSZ
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001641172-25-000990
Chunk: 1161

Company: My Size, Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1
Chunk 1161
---
 ●
    increased
    operating expenses and cash requirements;

    ●
    the
    assumption of additional indebtedness or contingent liabilities;

    ●
    assimilation
    of operations, intellectual property and products of an acquired company, including difficulties associated with integrating new
    personnel;

    ●
    the
    diversion of our management’s attention from our existing programs and initiatives in pursuing such a strategic merger or acquisition;

    ●
    retention
    of key employees, the loss of key personnel, and uncertainties in our ability to maintain key business relationships;

18

    ●
    risks
    and uncertainties associated with the other party to such a transaction, including the prospects of that party and their existing
    technologies; and

    ●
    our
    inability to generate revenue from acquired technologies or products sufficient to meet our objectives in undertaking the acquisition
    or even to offset the associated acquisition and maintenance costs.

All
of the foregoing risks may be magnified as the cost, size or complexity of an acquisition or acquired company increases, or where the
acquired company’s products, market or business are materially different from ours, or where more than one integration is occurring
simultaneously or within a concentrated period of time. We may not be able to obtain the necessary regulatory approvals, including those
of antitrust authorities and foreign investment authorities, in countries where we seek to consummate acquisitions or make investments.
For those and other reasons, we may ultimately fail to consummate an acquisition, even if we announce the intended acquisition.

In
addition, we may require significant financing to complete an acquisition or investment, whether through bank loans, raising of equity
or debt or otherwise. We cannot assure you that such financing options will be available to us on reasonable terms, or at all. If we
are not able to obtain such necessary financing, it could have an impact on our ability to consummate a substantial acquisition or investment
and execute a future growth strategy. Alternatively, we may issue a significant number of shares as consideration for an acquisition,
which would have a dilutive effect on our existing shareholders. For example, in partial consideration for the acquisition of Orgad,
we agreed to issue up to 111,602 shares of our common stock and in the Naiz acquisition we issued 240,000 shares of our common stock.
Furthermore, if we undertake acquisitions, we may incur large one-time expenses and acquire intangible assets that could result in significant
future amortization expense.

If
we are not able to